Mutations in MYH7 cause autosomal dominant Laing distal myopathy. We present a family with a previously reported deletion (c.5186_5188delAGA, p.K1729del). Muscle pathology in one family member was characterized by an inflammatory myopathy with rimmed vacuoles, increased MHC Class I expression, and perivascular and endomysial muscle inflammation comprising CD3 + , CD4 + , CD8 + , and CD68 + inflammatory cells. Interestingly, this biopsy specimen contained TDP-43, p62, and SMI-31-positive protein aggregates typical of inclusion body myositis. These findings should alert physicians to the possibility that patients with MYH7 mutations may have muscle biopsies showing pathologic findings similar to inclusion body myositis.
Introduction
The inherited distal myopathies are a group of genetically heterogeneous muscle disorders characterized by weakness of the distal muscles of the arms and legs. They are caused by defects in several genes including TTN, DYSF, GNE, LDB3, and MYH7.
1 MYH7 (slow/b-cardiac myosin heavy chain 7) is expressed in both skeletal muscle and cardiac muscle, 2 and mutations can give rise to a familial hypertrophic or dilated cardiomyopathy 3 as well as several skeletal muscle disorders: Laing distal myopathy (MPD1; MIM# 160500), scapuloperoneal myopathy (MIM# 181430), and myosin storage myopathy (MSM)/hyaline body myopathy (MIM# 608358).
Laing distal myopathy [4] [5] [6] [7] presents clinically with weakness and atrophy of the forearm finger extensors and the This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
anterior compartment muscles of the legs. 1 Only within the last decade, MYH7 has been identified as a gene causing distal skeletal myopathy. 6 Although clinical findings have been fairly uniform, biopsy findings have proven to be more varied. Observed features include type 1 fiber atrophy, myofiber degeneration with regeneration, endomysial fibrosis, and fatty replacement. In addition, findings suggestive of mitochondrial dysfunction such as ragged red fibers have also been noted. Rimmed vacuoles, similar to those seen in inclusion body myositis, are observed rarely. 5, 8 We present a patient with Laing distal myopathy with endomysial invasion by inflammatory cells on muscle biopsy and positive staining for markers associated with inclusion body myositis.
Case Report
We examined five members of this family (Fig. 1A) , four from generation III (III.7, III.9, III.13, III.15) and one from generation IV (IV.15). All subjects provided informed consent to participate in this study under a clinical research protocol approved by the NIH Combined Neuroscience Institutional Review Board.
The family traces their roots to German immigrants to the United States. The proband, III.15, is a 52-year-old male who first noted difficulty running as a teenager. This progressed in his early twenties, at which point he could not rise from a squat. In his early thirties he noticed atrophy of his quadriceps, and in his late forties he required a cane to ambulate. He came to our attention at the age of 51 years. On neurological examination, he showed weakness in his arms on wrist flexion and extension as well as finger flexion and extension, while in the lower extremities he exhibited hip flexion, knee extension, and severe ankle dorsiflexion and large toe extensor weakness. He had atrophy of the quadriceps and anterior compartment of the leg. His quadriceps atrophy and wrist and finger flexion weakness were reminiscent of sporadic IBM (sIBM). Muscle MRI of the lower extremities showed asymmetric atrophy and fatty replacement of the vastus intermedius and vastus medialis (Fig. 1B) . This type of asymmetry is typical of sIBM. 9 Particularly worrisome to the patient was that his rate of worsening had significantly increased over the past several years, and he had new onset of hand weakness over the past few years. Interestingly, his family tree (Fig. 1A) suggested that other family members might also be affected with muscle disease.
To further characterize the phenotype in this family, additional family members underwent neurological examination at our institution (Fig. 1C ) (summarized in Table 1 ). Subject III.9 is a 62-year-old man who first developed difficulty walking at the age of 10 years. He was able to play baseball in high school but was not a fast runner. He noted in his early thirties that his gait was stable when wearing boots that provided ankle support. Exam showed wrist drop and finger extension weakness (Fig. 1C) . He had a left gastrocnemius muscle biopsy, for which we only have a report, which notes that there was a small number of necrotic but no regenerating fibers. There was no inflammation and no vacuoles. medialis. An arrow points to an area of atrophy and fatty replacement. (C) Selected physical findings from subjects with MYH7 mutation. Clockwise from top left: III.13 has significant calf hypertrophy; III.9 displays anterior compartment atrophy; quadriceps atrophy is also observed in III.7; III.9 showing limited wrist extension due to weakness of the extensor compartment of the arm. The "hanging big toe sign" was observed in all patients; in this image, the foot of IV.15 is shown.
Subject III.13 is a 54-year-old man who initially noted frequent falls while playing sports in his late thirties. His exam showed quadriceps and tibialis anterior atrophy, toe dorsiflexion weakness, and calf hypertrophy (Fig. 1C) .
IV.15 is a 28-year-old man who was asymptomatic but noted to have mild weakness of toe dorsiflexion on exam (Fig. 1C) .
III.7 is a 63-year-old man who developed difficulty walking in his early teenage years. Gait instability slowly progressed until he started to fall frequently in his fifties. On exam he had mild facial weakness, mild-to-moderate proximal lower extremity weakness and atrophy, (Fig. 1C) and weakness of ankle dorsiflexion and toe extension. All family members with the exception of IV.15 had involvement of the distal upper limb (Table 1) .
Given the mixed clinical features at presentation of our index patient, we decided to proceed with muscle tissue evaluation before genetic testing. A first biopsy of the right thigh of the index patient done several years before was only moderately useful, showing extensive fatty replacement, endomysial fibrosis, fiber size variation, and endomysial perivascular inflammation with rare vacuolated fibers ( Fig. 2A-C) . We performed an additional muscle biopsy of the left biceps and performed immunostaining for inflammatory cells and proteinaceous aggregates (Figs. 2, 3) .
On frozen H&E stains, there was fiber size variability with rounded and polygonal myofiber atrophy, rare hypertrophied fibers, and occasional angular atrophic fibers (Fig. 2D ). Most importantly, there were also many areas of primary endomysial inflammation (Fig. 2D-F and Fig. S1A-C) , with chronic mononuclear inflammatory cells surrounding and invading nonnecrotic fibers as well as perivascular chronic inflammation seen on frozen ( Fig. 2H and Fig. S1B ) and paraffin sections. Many fibers contained small to medium-sized vacuoles, both subsarcolemmal and sarcoplasmic in location (Fig. 2G and Fig.  S1E and F) . These vacuoles were blue-rimmed on H&E staining and red rimmed on Gomori trichrome staining. Many of the vacuoles were also acid phosphatase positive.
In addition, we noted myofiber degeneration and necrosis with occasional regeneration. There were many fibers undergoing myophagocytosis, and acid phosphatase staining was increased in degenerating and necrotic fibers and in the areas of myophagocytosis (Fig. 2I ). There were many COX-negative fibers, some of which were SDH dark (Fig. 2J) . Ragged red fibers were also seen. Many fibers also showed increased subsarcolemmal NADH staining (not shown).
Immunostaining demonstrated markedly increased MHC Class I staining in nonnecrotic myofibers (Fig. 3A) , and also in perimysial regions (Fig. 3E ). There were many scattered CD4 + (Fig. 3C ), CD8 + (Fig. 3D) , and CD68 + cells (Fig. 3F ) in the endomysium and invading degenerating fibers as well as in the perivascular infiltrates. CD20 + cells were rare. Significantly, many muscle fibers were positive for proteinaceous inclusions commonly seen in sporadic inclusion body myositis (s-IBM): TDP-43, p62, and SMI-31 (Fig. 3G-I) . We are not aware of cases in which these antibodies have been tested in cases of Laing distal myopathy. Testing of the proband revealed a c.5186_5188delAGA (p.K1729del) deletion in exon 36 of MYH7. Additional affected family members also tested positive for the same mutation.
Discussion
Mutations in MYH7 cause Laing distal myopathy (MPD1), myosin storage/hyaline body myopathy, scapuloperoneal myopathy, and familial hypertrophic or dilated cardiomyopathy. In this report, we present a family of German ancestry with a c.5186_5188delAGA (p.K1729del) deletion in exon 36 of MYH7. A similar mutation resulting in the same amino acid deletion is also associated with a skeletal myopathy reported previously in an American family of Italian descent and in a family from Spain. 6, [10] [11] [12] Onset of symptoms in our kindred was in the teenage years (Table 1) , with two exceptions. Subject III.9 developed symptoms in his thirties, and IV.15 denied symptoms despite having toe extensor weakness on exam. The distribution of weakness in the patients we examined was in toe and ankle dorsiflexion initially, then progressed to involve finger extensors, in agreement with other reports typical of patients with Laing distal myopathy. Our index patient, however, had distinct finger flexor weakness.
The biopsy findings in Laing early onset distal myopathy are pleiotropic. Both Muelas et al. and Lamont et al. have summarized many of the reported findings. 10, 13 Myofiber size variability, degenerating and regenerating fibers, endomysial fibrosis with fatty replacement, type 1 fiber atrophy, ragged red fibers, and sarcoplasmic inclusions have all been observed. Cores and minicores have been reported as well in patients with mutations in MYH7. 10, 13 Inflammation is seen in other muscular dystrophies including the dystrophinopathies, dysferlinopathies, and facioscapulohumeral muscular dystrophy among others. A single report has shown rare inflammation mostly surrounding and within degenerating fibers in a patient with a MYH7 mutation.
14 The nature of the infiltrate was noted to be mostly CD4 and CD68 positive, with only faint expression of MHC-I. In the case presented here, the presence of primary inflammation in combination with red-rimmed vacuoles and positive staining for proteinaceous aggregates has not been reported in Laing myopathy patients.
The presence of primary inflammation and redrimmed vacuoles is a hallmark of inclusion body myositis. In the index patient, we have demonstrated T-cell predominant inflammatory infiltrates surrounding and invading nonnecrotic fibers and increased MHC-I staining. We have also observed red-rimmed vacuoles and positive staining for TDP-43, p62, and phospho-Tau (SMI-31)-positive protein aggregates. A recent study by Brady et al. found that in biopsies in which vacuoles were present, the combination of a specific pattern of p62 staining, and increased MHC-I staining yielded a sensitivity of 93% and specificity of 100% for IBM, demonstrating the utility of this particular stain as a diagnostic marker. 15 This case, though, demonstrates that some inherited myopathies may also yield similar findings on muscle biopsy and emphasizes the importance of the clinical exam.
Genetic testing provided the definitive diagnosis, confirming the pathogenic mutation in MYH7. The mixed clinical presentation as well as the pathology findings raises the remote possibility that the index case suffers from both Laing distal myopathy and sporadic IBM. The co-occurrence of an inflammatory myopathy with an inherited myopathy has been previously reported 16 and we have seen other sporadic IBM patients with inherited neuromuscular diseases, including FSHD (pers. comm.). In order to determine whether our patient had IBM in additional to Laing distal myopathy, further investigations to identify protein aggregates labeled for SMI 31 and p62 in this and other distal myopathies with rimmed vacuoles would be helpful. These issues notwithstanding, this case report highlights the need to consider genetic muscle disease in patients with an atypical IBM history and phenotype (in our case, positive family history, weakness onset before the age of 45, and wrist/finger extensor weakness greater than flexor weakness) even in the context of classic IBM pathology.
